首页 | 本学科首页   官方微博 | 高级检索  
     

肿瘤医院门诊患者退药情况分析
引用本文:张巧珍,黄雪玲,王人英,王艺,雷纬成. 肿瘤医院门诊患者退药情况分析[J]. 临床合理用药杂志, 2013, 6(1): 7-9
作者姓名:张巧珍  黄雪玲  王人英  王艺  雷纬成
作者单位:中山大学肿瘤防治中心药剂科
摘    要:目的分析该院门诊患者退药情况,针对存在的问题提出改进措施,为临床合理用药提供参考。方法选择502例门诊患者的退药清单,按退药原因、退药类型、退药金额进行统计分析。结果退药原因前3位为药品的不良反应(56.57%)、病情变化(13.15%)、患者拒绝治疗或检查(9.96%);退药类型分布前3位为抗肿瘤药36种(22.09%),抗肿瘤辅助治疗药36种(22.09%),抗生素类药22种(14.11%)。退药金额前3位为抗肿瘤药424479.48元,抗肿瘤辅助药166864.62元,抗生素56039.02元。结论应加强医、药、患之间的沟通,努力提高服务意识;加强退药管理,规范退药程序;加强药品不良反应监测工作;加强业务学习、及时总结,是减少退药的有效措施。

关 键 词:门诊  肿瘤医院  退药

The analysis of drug withdrawal in cancer hospital outpatient
Affiliation:ZHANG Qiao-zhen,HUANG Xue-ling,WANG Ren-ying,et al.Department of Pharmacy,Sun Yat-sen University Cancer Center,Guangzhou,Guangdong 510060,China
Abstract:Objective To analysis the drug withdrawal of hospital outpatient,improvement measures are proposed for the existing problems,and provide a reference for the clinical use of drugs.Methods Selected a list of 502 cases of outpatient drug withdrawal,analyzed the reasons of drug withdrawal and drug withdrawal type and amount of drug withdrawal.Results Major drug withdrawal due to adverse drug reactions(56.57%),changes in condition(13.15%),the patient refused treatment or examination(9.96%) ;The major drug withdrawal type contain anticancer and anti-tumor adjuvant treatment of drug and antibiotic medicines,and the percentage were 22.09%,22.09%,14.11%.The drug withdrawal fee is mainly due to the antineoplastic agents,anti-tumor adjuvant drugs,and antibiotics,the withdrawal amount respectively is 424 479.48 yuan,166 864.62 yuan and 56 039.02 yuan.Conclusion Should strengthen communication between doctors,pharmacists,patients,raise awareness of service;Strengthen the management of drug withdrawal,to regulate drug withdrawal program;Strengthen the monitoring of adverse drug reactions;Strengthen business learning,sum up effective measure to reduce drug withdrawal.
Keywords:Outpatient  Cancer Hospital  Drug withdrawal
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号